SG
LLY icon

StoneX Group’s Eli Lilly LLY Stock Holding History

StoneX Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.06M Sell
6,592
-4,543
-41% -$4.61M 0.33% 57
2025
Q4 		$12M Sell
11,135
-11
-0.1% -$10.5K 0.52% 32
2025
Q3 		$8.5M Buy
11,146
+118
+1% +$87.8K 0.37% 52
2025
Q2 		$8.6M Buy
11,028
+2,814
+34% +$2.19M 0.42% 43
2025
Q1 		$6.78M Buy
8,214
+229
+3% +$191K 0.37% 51
2024
Q4 		$6.16M Buy
7,985
+1,504
+23% +$1.25M 0.34% 61
2024
Q3 		$5.74M Buy
6,481
+467
+8% +$420K 2.58% 3
2024
Q2 		$5.44M Sell
6,014
-50
-0.8% -$40K 2.55% 3
2024
Q1 		$4.72M Buy
6,064
+77
+1% +$54.8K 2.44% 3
2023
Q4 		$3.49M Sell
5,987
-21
-0.3% -$12.3K 1.86% 3
2023
Q3 		$3.23M Buy
6,008
+66
+1% +$34K 1.78% 3
2023
Q2 		$2.79M Buy
5,942
+286
+5% +$120K 1.57% 4
2023
Q1 		$1.94M Sell
5,656
-129
-2% -$43.5K 1.16% 10
2022
Q4 		$2.12M Buy
+5,785
New +$2.05M 0.31% 50
2022
Q2 		– Sell
-6,665
Closed -$1.91M – 646
2022
Q1 		$1.91M Buy
6,665
+906
+16% +$233K 0.18% 108
2021
Q4 		$1.59M Buy
5,759
+162
+3% +$41.1K 0.18% 112
2021
Q3 		$1.29M Sell
5,597
-446
-7% -$110K 0.19% 120
2021
Q2 		$1.39M Buy
6,043
+1,355
+29% +$272K 0.21% 103
2021
Q1 		$876K Buy
4,688
+38
+0.8% +$7.43K 0.16% 136
2020
Q4 		$785K Buy
4,650
+277
+6% +$41.4K 0.17% 127
2020
Q3 		$647K Sell
4,373
-585
-12% -$90.5K 0.21% 120
2020
Q2 		$814K Buy
4,958
+66
+1% +$10.1K 0.31% 87
2020
Q1 		$679K Buy
4,892
+569
+13% +$78.2K 0.36% 81
2019
Q4 		$568K Buy
4,323
+63
+1% +$7.3K 0.23% 131
2019
Q3 		$476K Buy
+4,260
New +$474K 0.3% 119

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

StoneX Group's LLY Position: Q1 2026 in Review

StoneX Group reduced its Eli Lilly (LLY) stake by 41% in Q1 2026, selling an estimated $4.61M and leaving 6,592 shares worth $6.06M. The position accounts for 0.33% of the portfolio, ranked #57.

StoneX Group first reported a position in LLY in Q3 2019 and has held it in 25 quarters since. The position peaked at $12M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • StoneX Group held 6,592 shares of Eli Lilly worth $6.06M as of Q1 2026.
  • StoneX Group sold 4,543 Eli Lilly shares in Q1 2026, an estimated $4.61M.
  • Eli Lilly made up 0.33% of StoneX Group's portfolio in Q1 2026, its #57 holding.
  • StoneX Group first reported a position in Eli Lilly in Q3 2019 and has held it in 25 quarters since.
  • StoneX Group's Eli Lilly position peaked at $12M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.